Mary Imogene Bassett Hospital is a clinical research site located in Cooperstown, New York, United States 13326.
Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.
Mary Imogene Bassett Hospital has participated in 80 clinical trials with 45 currently active.
Therapeutic areas: Plasma Cell Myeloma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7.
Sponsors: ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology.
Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Mary Imogene Bassett Hospital has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Mary Imogene Bassett Hospital has 80 clinical trials on record, with 45 currently active. Their work covers Plasma Cell Myeloma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7.
Mary Imogene Bassett Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.